By combining the data from the UPMC-REMAP-COVID19 trial, the only U.S.-based trial to test corticosteroids, and data from six other randomized controlled trials around the world that tested the effect of corticosteroids, researchers were able to “find that...
University of Pittsburgh Medical Center
UPMC Enterprises on a $1b Healthcare Investment Mission out of Pittsburgh, PA
University of Pittsburgh Medical Center (UPMC), a formidable academic medical center in its own right, emerged at the beginning of the year as a major biotech investor. With UPMC considering investments around the world at all stages, the investment vehicle associated...
Monoclonal Antibody that Neutralizes SARS-CoV-2, Forms Venture
University of Pittsburgh School of Medicine scientists have isolated the smallest biological molecule to date that completely and specifically neutralizes the SARS-CoV-2 virus, which is the cause of COVID-19. This antibody component, which is 10 times smaller...
University of Pittsburgh Medical Center Commits $1 Billion to Life Sciences Investments
University of Pittsburgh Medical Center (UPMC) Enterprises announced that it will deploy $1 billion to develop new drugs, diagnostics and devices by 2024. UPMC Enterprises seeks investments and partners globally that complement the scientific and commercial work...